You are here
Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug
Primary tabs
Tue, 2022-12-06 11:09 — mike kraft
Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug Pfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline. Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/32SI7DKH6JJAVC6HSWO7WE2E6Q.jpg)
...
Pfizer already has a COVID antiviral pill Paxlovid, which the drugmaker expects to generate about $22 billion in revenue this year.
...
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments